Pra (PRAA) Revenue Growth (1y) (2010 - 2026)
Powered by 
Analysis
Pra (PRAA) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | 16.50% |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | 114.91% |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | 62.05% |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | 16.26% |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | -5.80% |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | 0.51% |
| 10 | Pra | 790.61 Mn | 725.61 Mn | 356.41 Mn | 29.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.37% |
| Mar 31, 2026 | 16.66% |
| Dec 31, 2025 | 13.69% |
| Sep 30, 2025 | 10.54% |
| Jun 30, 2025 | 1.22% |
| Mar 31, 2025 | 5.49% |
| Dec 31, 2024 | 32.43% |
| Sep 30, 2024 | 30.05% |
| Jun 30, 2024 | 35.84% |
| Mar 31, 2024 | 64.40% |
| Dec 31, 2023 | -0.64% |
| Sep 30, 2023 | -11.59% |
| Jun 30, 2023 | -18.98% |
| Mar 31, 2023 | -35.38% |
| Dec 31, 2022 | -13.27% |
| Sep 30, 2022 | -7.16% |
| Jun 30, 2022 | -9.58% |
| Mar 31, 2022 | -16.88% |
| Dec 31, 2021 | -6.18% |
| Sep 30, 2021 | -1.56% |